Completion of non-exclusive discounts according to § 130a para. 8 SGB V with any possibility to conclude at so-called ‘Open-House contracts’ for medicinal active substances Teriparatid and Palonosetron.
Completion of non-exclusive discounts according to § 130a para. 8 SGB W at any time with a so-called closing option ‘open-house contracts’ for pharmaceutical active substances zonisamide and xylometazolin.
Completion of several open-house contracts according to § 130a para. 8 SGB V with pharmaceutical companies to selected active substances (see point II.1.5).
Completion of non-exclusive discounts according to § 130a para. 8 SGB W at any time with a so-called closing option ‘open-house contracts’ for Aripiprazole and Tramadol/Paracetamol.